News
CamSOC2024 : Cambridge Symposium on Oesophageal Cancer – 2024
7 Nov 2024
Join us on Thursday 7 November, 8:30–18:00, at the CRUK Cambridge Institute, to learn about the latest fundamental, translational, and clinical advances in oesophageal cancer research.
Two Centre members honoured for excellence in life sciences
9 Jul 2024
Congratulations to Dr David Adams and Dr Emma Rawlins on their election to the European life sciences organisation, EMBO.
Thoracic Cancer Programme Seminar Series
27 Jun 2024
Come and find out what's new in thoracic cancer on Thursday 27 June, 16:00–18:00 at the School of Clinical Medicine, Cambridge Biomedical Campus.
What’s New in Thoracic Cancer seminar series
6 Jun 2024
All are welcome to join us on Thursday 27 June, 16:00-18:00 at the Theo Chalmers Lecture Theatre, School of Clinical Medicine Building, Cambridge Biomedical Campus.
Cambridge scientists benefit from Cancer Research UK funding boost
20 May 2024
Funding totalling almost £6 million has been awarded to doctors and scientists in the East of England to boost research into life-saving cancer treatments and services.
Improving risk stratification in smoking-related lung cancer
18 Apr 2024
New research sheds light on changes in gene expression that increase risk of lung cancer in smokers.
New trial brings screening for oesophageal cancer closer
9 Jan 2024
A man from Cambridge is the first to join the surveillance part of a clinical trial that could see routine screening for oesophageal cancer introduced into the NHS, potentially halving deaths from this cancer every year.
Cambridge Lung Cancer Symposium 2023
3 Nov 2023
Join us on Friday 3 November, 8:30–18:00, at the CRUK Cambridge Institute, Cambridge Biomedical Campus
World Head and Neck Cancer Day 2023
25 Jul 2023
To mark World Head and Neck Cancer Day on Thursday 27 July, our research and clinical teams ran an information and activity stand in the Oncology Day Unit at Addenbrooke’s.
Funding for new approach to detect and treat therapy-resistant lung cancer
11 Jul 2023
£650,000 has been awarded to develop novel imaging, AI-methods, and targeted treatment for therapy-resistant lung cancer.